BamSEC and AlphaSense Join Forces
Learn More

Arena Pharmaceuticals Inc

Formerly NASDAQ: ARNA
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.59
from 10-K ~1 page Arena Pharmaceuticals, Inc. 2021 Long-Term Incentive Plan Restricted Stock Unit Award Grant Notice
12/34/56
EX-10.53
from 10-K 18 pages Arena Pharmaceuticals, Inc. 2021 Long-Term Incentive Plan Adopted by the Compensation Committee: April 19, 2021 Approved by the Stockholders: June 11, 2021 Amended and Restated by the Compensation Committee: February 8, 2022 1. General
12/34/56
EX-10.30
from 10-K 3 pages Second Amended and Restated Executive Officer Eligibility Notice Arena Pharmaceuticals, Inc. Second Amended and Restated Severance Benefit Plan Eligibility Notice
12/34/56
EX-10.29
from 10-K 24 pages Arena Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan
12/34/56
EX-10.5
from 10-K 4 pages Omnibus Amendment to Leases for Buildings D, E, F and G
12/34/56
EX-10.3
from 10-Q 8 pages Arena Pharmaceuticals, Inc., 2021 Long-Term Incentive Plan Performance Restricted Stock Unit Grant Agreement
12/34/56
EX-10.2
from 10-Q 3 pages July 6, 2021 Base Salary
12/34/56
EX-10.1
from 10-Q 21 pages Arena Pharmaceuticals, Inc. 2021 Long-Term Incentive Plan Adopted by the Compensation Committee: April 19, 2021 Approved by the Stockholders: June 11, 2021 Amended and Restated by the Compensation Committee: October 5, 2021 1. General
12/34/56
EX-10.9
from 10-Q 2 pages Arena Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan Eligibility Notice
12/34/56
EX-10.2
from 10-Q 21 pages Arena Pharmaceuticals, Inc. 2021 Long-Term Incentive Plan Adopted by the Compensation Committee: April 19, 2021 Approved by the Stockholders: June 11, 2021 Amended and Restated by the Compensation Committee: July 16, 2021 1. General
12/34/56
EX-10.1
from 10-Q 14 pages Arena Pharmaceuticals, Inc. Amended and Restated 2020 Long-Term Incentive Plan
12/34/56
EX-10.50
from 10-K 8 pages Arena Pharmaceuticals, Inc., 2020 Long-Term Incentive Plan Performance Restricted Stock Unit Grant Agreement
12/34/56
EX-10.45
from 10-K 14 pages Arena Pharmaceuticals, Inc. Amended and Restated 2020 Long-Term Incentive Plan
12/34/56
EX-10.22
from 10-K 10 pages October 27, 2020 Mr. Kevin Lind Re: Separation Agreement
12/34/56
EX-10.12
from 10-K 11 pages Consulting Services Agreement
12/34/56
EX-10.11
from 10-K 17 pages January 13, 2020 Steven Spector Re: Transition and Retirement Agreement
12/34/56
EX-10.2
from 10-K 14 pages Indemnification Agreement
12/34/56
EX-10.1
from 10-K 14 pages Indemnification Agreement
12/34/56
EX-10.1
from 10-Q 14 pages Arena Pharmaceuticals, Inc. Amended and Restated 2020 Long-Term Incentive Plan
12/34/56
EX-10.8
from 10-Q 7 pages Services Agreement
12/34/56